Systemic Inflammatory Response Syndrome
103
11
12
60
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Research Maturity
60 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.8%
8 terminated out of 103 trials
88.2%
+1.7% vs benchmark
16%
16 trials in Phase 3/4
10%
6 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 60 completed trials
Clinical Trials (103)
CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome
Dynamics of microRNA Expression and Systemic Inflammatory Response in POCD After Cardiac Surgery
Modulation of Molecular Fingerprinting in Pediatric Sepsis
Conventional Ultrafiltration Versus Dilutional Ultrafiltration in Pediatric CPB Patients
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
Goal-directed Resuscitative Interventions During Pediatric Inter-facility Transport (The GRIPIT Trial)
Perioperative Blood Adiponectin Dynamics and Systemic Infflamatory Response After Major Colorectal Surgery
A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery
High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic Shock
Registry for Hemoperfusion of Covid-19 ICU Patients
Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)
Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock